Viewing Study NCT06790303


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-06-20 @ 4:10 PM
Study NCT ID: NCT06790303
Status: TERMINATED
Last Update Posted: 2025-06-04
First Post: 2025-01-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None Feladilimab View
None Iplimumab View